Revenue
0 USD
2023 Q4 · USD
Market value is not computed: no listed ticker is recorded for this company.
29 filing records in this dataset, filed from 2021-02-23 to 2026-02-26. Reported financial figures are available; chart coverage varies by period.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.
This issuer has insider filings in the store, but no transaction in this window or code group.
0 USD
2023 Q4 · USD
-6.94 million USD
2023 Q4 · USD
-6.94 million USD
2023 Q4 · USD
6000 USD
51306712 shares
129.16% · 28.9 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
-23.6 million USD
2024-04-01 – 2025-03-31
-19.6 million USD
2024-04-01 – 2025-03-31
Latest filing vintage with reviewed corrections applied; these values remain separate from issuer-reported figures. Annual charts exclude incomplete years.
Latest filing recorded: 2026-02-26.
Financial data available through: 2023-12-31.
Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 77,000
–
Current period
USD 0
–
0 − 77000 = -77000 USD
77000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source0 USD · 2023-01-01 – 2023-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 26.75 million
–
Current period
−USD 82.95 million
–
-82954000 − -26754000 = -56200000 USD
-26754000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source-82954000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 22.56 million
–
Current period
−USD 21.95 million
–
-21948000 − -22557000 = 609000 USD
-22557000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source-21948000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 101,000
–
Current period
USD 0
–
0 − 101000 = -101000 USD
101000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source0 USD · 2023-01-01 – 2023-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2021 2021-01-01 – 2021-12-31 | 426000 | 22287000 Derived | -21861000 | 1404000 Derived | -23265000 | -19951000 Derived | Source
|
| 2022 2022-01-01 – 2022-12-31 | 77000 | 24423000 Derived | -24346000 | 2408000 Derived | -26754000 | -22658000 Derived | Source
|
| 2023 2023-01-01 – 2023-12-31 | 0 | 29746000 Derived | -29746000 | 53208000 Derived | -82954000 | -21948000 Derived | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2021 | Revenue | 426000 |
|
| 2022 | Revenue | 77000 |
|
| 2023 | Revenue | 0 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2021 | Year over year | No prior comparable period |
|
| 2022 | Year over year | -81.9% |
|
| 2023 | Year over year | -100% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2021-12-31 | Operating margin | Not reported |
|
| 2022 | Operating margin | -31,618.2% |
|
| 2023 | Operating margin | Not reported |
|
| 2021-12-31 | Net margin | Not reported |
|
| 2022 | Net margin | -34,745.5% |
|
| 2023 | Net margin | Not reported |
|
| 2021 | Free cash flow margin | -4,683.3% |
|
| 2022 | Free cash flow margin | -29,426% |
|
| 2023 | Free cash flow margin | Not reported |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2021 | Operating cash flow | -19548000 |
|
| 2022 | Operating cash flow | -22557000 |
|
| 2023 | Operating cash flow | -21948000 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2021 | Free cash flow | -19951000 |
|
| 2022 | Free cash flow | -22658000 |
|
| 2023 | Free cash flow | -21948000 |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2021 | Liabilities / assets | 310.6% |
|
| 2022 | Liabilities / assets | 90.4% |
|
| 2023 | Liabilities / assets | 456.1% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2021 | Current assets / current liabilities | 0.01× |
|
| 2022 | Current assets / current liabilities | 0.02× |
|
| 2023 | Current assets / current liabilities | 0.05× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2021 2021-01-01 – 2021-12-31 | −USD 23.27 million Exact valueExact value: -23265000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 19.55 million Exact valueExact value: -19548000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 403,000 Exact valueExact value: 403000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 19.95 million Calculation and evidence-19548000 − 403000 USD Exact free cash flow: -19951000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2021 2021-01-28 – 2021-12-31 | −USD 990,638 Exact valueExact value: -990638 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.52 million Exact valueExact value: -1523725 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2022 2022-01-01 – 2022-12-31 | −USD 26.75 million Exact valueExact value: -26754000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 22.56 million Exact valueExact value: -22557000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 101,000 Exact valueExact value: 101000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 22.66 million Calculation and evidence-22557000 − 101000 USD Exact free cash flow: -22658000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2023 2023-01-01 – 2023-12-31 | −USD 82.95 million Exact valueExact value: -82954000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 21.95 million Exact valueExact value: -21948000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 0 Exact valueExact value: 0 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 21.95 million Calculation and evidence-21948000 − 0 USD Exact free cash flow: -21948000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
29 filings · 1,004 latest values · 1,004 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001845459, 1845459, edgar:1845459
Also known as GRAF ACQUISITION CORP. IV, Graf Acquisition Corp. IV, NKGen Biotech, Inc., NKGen Biotech, Inc.